1-9 of 9
Katharina Gotze, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal Residual Disease Monitoring in Acute Myeloid Leukemia (AML) with Translocation t(8;21)(q22;q22): Results of the AML Study Group (AMLSG)

Mridul Agrawal, MD, Andrea Corbacioglu, PhD, Peter Paschka, MD, Daniela Weber, Verena I. Gaidzik, MD, Nikolaus Jahn, MD, Andrea Kündgen, MD, Thomas Kindler, MD, Mohammad Amen Wattad, MD, Michael Lübbert, MD, Walter Fiedler, MD, Katharina Götze, MD, Mark Ringhoffer, MD, Jan Schleicher, MD, Elisabeth Lange, MD, Gerhard Held, MD, Martin Griesshammer, MD, Richard Greil, MD, Heinz Kirchen, MD, Elisabeth Koller, MD, Felicitas Thol, MD, Jürgen Krauter, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, MD, Richard F. Schlenk, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2016) 128 (22): 1207.
https://doi.org/10.1182/blood.V128.22.1207.1207
Published: 2016
Journal Articles

Phase I/II Study on Cytarabine and Idarubicin Combined with Escalating Doses of Clofarabine in Untreated Patients with Acute Myeloid Leukemia and High Risk for Induction Failure (AMLSG 17-10 CIARA)

Juergen Krauter, MD, Walter Fiedler, MD, Richard F. Schlenk, MD, Peter Paschka, MD, Felicitas Thol, MD, Michael Lübbert, MD, Mohammad Amen Wattad, MD, Mareike Verbeek, Christian Koenecke, MD, Barbara Neuhaus, Maxim Kebenko, Melanie Janning, Konstanze Dohner, MD, Verena I. Gaidzik, MD, Heiko Becker, MD, Christine Greil, MD, Peter Reimer, MD, Katharina Götze, MD, Hartmut Döhner, MD, Arnold Ganser, MD, Michael Heuser, MD
Journal: Blood
Blood (2016) 128 (22): 4038.
https://doi.org/10.1182/blood.V128.22.4038.4038
Published: 2016
Journal Articles

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Stefanie Jilg, MD, Johanna Kauschinger, MDcal student, Veronika Reidel, MDcal student, Catharina Müller-Thomas, MD, Richard Hauch, MDcal student, Johannes Schauwecker, MD, Burkhard Schmidt, MD, Ulrike Höckendorf, Dipl. Humanbiol., Christian Peschel, MD, Katharina Götze, MD, Philipp J. Jost, MD
Journal: Blood
Blood (2016) 128 (22): 4297.
https://doi.org/10.1182/blood.V128.22.4297.4297
Published: 2016
Journal Articles

Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study

Uwe Platzbecker, MD, Ulrich Germing, MD, Aristoteles Giagounidis, MD PhD, Katharina Götze, MD, Philipp Kiewe, MD, Karin Tina Mayer, MD, Oliver Ottmann, MD, Markus Radsak, MD, Thomas Wolff, MD, Detlef Haase, MD, Monty Hankin, Dawn Wilson, Xiaosha Zhang, Abderrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD
Journal: Blood
Blood (2015) 126 (23): 2862.
https://doi.org/10.1182/blood.V126.23.2862.2862
Published: 2015
Journal Articles

Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study

Aristoteles Giagounidis, MD PhD, Uwe Platzbecker, MD, Ulrich Germing, MD, Katharina Götze, MD, Philipp Kiewe, MD, Karin Tina Mayer, MD, Oliver Ottmann, MD, Markus Radsak, MD, Thomas Wolff, MD, Detlef Haase, MD, Monty Hankin, Dawn Wilson, Xiaosha Zhang, Adberrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD
Journal: Blood
Blood (2015) 126 (23): 92.
https://doi.org/10.1182/blood.V126.23.92.92
Published: 2015
Journal Articles

An Adapted Gating Strategy Integrating a Myelomonocytic Window Is Necessary For Correct Flow Cytometric Diagnosis In a Large Proportion Of AML With Mutated NPM1

Miriam Kull, MD, Christian Langer, MD, Michela Tassara, MD, Christine Schoepflin, Olena Bayer, Carina Morlok, Andrea Kündgen, M.D., Helmut R. Salih, MD, Thomas Kindler, MD, Heinz-August Horst, MD, Michael Lübbert, MD, Hans Salwender, MD, Katharina Götze, MD, Felicitas Thol, MD, Arnold Ganser, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD, Michaela Feuring-Buske, MD
Journal: Blood
Blood (2013) 122 (21): 2593.
https://doi.org/10.1182/blood.V122.21.2593.2593
Published: 2013
Journal Articles

Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Catharina Müller-Thomas, MD, Martina Rudelius, MD, Ina Rondak, PhD, Torsten Haferlach, MD, Julie Schanz, MD, Burkhard Schmidt, MD, Markus Kremer, MD, Ulrich Germing, MD, Uwe Platzbecker, MD, PhD, Christian Peschel, Katharina Götze, MD
Journal: Blood
Blood (2013) 122 (21): 2797.
https://doi.org/10.1182/blood.V122.21.2797.2797
Published: 2013
Journal Articles

Possible Biomarkers To Predict Response In Patients With Myelodysplastic Syndromes (MDS) Or Acute Myeloid Leukemia (AML) Treated With 5-Azacitidine

Andrea Kuendgen, MD, Catharina Müller-Thomas, MD, Petra Urbaniak, Michael Lauseker, Torsten Haferlach, MD, Tamara Alpermann, Andreia Albuquerque, PhD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Barbara Hildebrandt, PhD, Brigitte Royer-Pokora, PhD, Norbert Gattermann, MD, Rainer Haas, MD, Ulrich Germing, MD, Katharina Götze, MD
Journal: Blood
Blood (2013) 122 (21): 2757.
https://doi.org/10.1182/blood.V122.21.2757.2757
Published: 2013
Journal Articles

Imatinib and Leptomycin B Are Effective in Overcoming Imatinib-Resistance Due to Bcr-Abl Amplification or Clonal Evolution but Not Due to Bcr-Abl Kinase Domain Mutation.

Rama K. Kancha, MSc, Cornelius Miething, MD, Nikolas V. Bubnoff, MD, Katharina Gotze, MD, Christian Peschel, MD, Justus Duyster, MD
Journal: Blood
Blood (2005) 106 (11): 2003.
https://doi.org/10.1182/blood.V106.11.2003.2003
Published: 2005